SCHEMBL25459477

SCHEMBL25459477

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4oc(-c5cccc(-n6c7ccccc7c7cc(-c8nc9ccccc9o8)ccc76)c5)nc4c3)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 6/20 0.47
▸ KDM4E B2RXH2 5/20 0.47
▸ HSD17B10 Q99714 4/20 0.47
▸ HPGD P15428 4/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ TP53 P04637 3/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ PKM P14618 1/20 0.47
▸ HPSE Q9Y251 7/20 0.44
▸ NPC1 O15118 5/20 0.41
▸ RAB9A P51151 3/20 0.40
▸ CASP3 P42574 3/20 0.40
▸ SENP7 Q9BQF6 3/20 0.40
▸ SENP6 Q9GZR1 3/20 0.40
▸ SENP8 Q96LD8 2/20 0.40
▸ HCRTR1 O43613 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23118730 0.97 KDM4E (0.49) SMN1; SMN2KDM4EHSD17B10HPGDKMT2A
SCHEMBL25459466 0.95 HPSE (0.47) SMN1; SMN2KDM4EHSD17B10HPGDKMT2A
SCHEMBL25751763 0.95 HPSE (0.49) SMN1; SMN2KDM4EHSD17B10HPGDKMT2A
SCHEMBL23118531 0.95 KDM4E (0.47) SMN1; SMN2KDM4EHSD17B10HPGDKMT2A
SCHEMBL25459683 0.94 KDM4E (0.47) SMN1; SMN2KDM4EHSD17B10HPGDKMT2A
SCHEMBL23118822 0.94 KDM4E (0.48) SMN1; SMN2KDM4EHSD17B10HPGDKMT2A
SCHEMBL25459403 0.94 HPSE (0.48) SMN1; SMN2KDM4EHSD17B10HPGDKMT2A
SCHEMBL23079976 0.93 SMN1; SMN2 (0.45) SMN1; SMN2KDM4EHSD17B10HPGDKMT2A
SCHEMBL25459475 0.93 NPC1 (0.43) SMN1; SMN2KDM4EHSD17B10HPGDKMT2A
SCHEMBL23079891 0.93 SMN1; SMN2 (0.45) SMN1; SMN2KDM4EHSD17B10HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20230145469-A1 ORGANIC LIGHT EMITTING ELEMENT LG DISPLAY CO., LTD. (KR) 2023-05-11 — — US disclosed
US-20230145469-A1 ORGANIC LIGHT EMITTING ELEMENT LG DISPLAY CO., LTD. (KR) 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOX1, XDH, PPOX SMN1; SMN2 4240/4885KDM4E 2446/4885HSD17B10 1994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback